DGAP-Adhoc: H&R AG: Capital increase through contribution of 51 % of the Chinese activities of the Hansen & Rosenthal Group


H&R AG  / Key word(s): Corporate Action/Capital Increase

17.09.2014 19:24

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Ad hoc notification conforming to 
article 15 of the German law governing 
the trading of securities (WpHG) 

H&R AG: Capital increase through contribution of 51 % of the Chinese
activities of the Hansen & Rosenthal Group

Salzbergen (Germany), 17th September 2014. The board of directors of H&R
Aktiengesellschaft (ISIN DE0007757007) has today decided, with the
agreement of the supervisory board, in favour of an increase in capital
based in turn on authorised capital, subject to the exclusion of
subscription rights of existing shareholders. The Hansen & Rosenthal Group,
of Hamburg (Germany), will contribute 51 % of its China-based activities
(bundled in the H&R China Holding GmbH, Hamburg) to H&R AG, in exchange for
an issue of new shares.

H&R AG undertakes, on its part and in exchange for the above contribution,
to provide the Hansen & Rosenthal Group with 5,487,042 new shares. The
issue price of the new shares will be EUR7.10 per new share in the company.
The recording of this increase in capital in the company register will be
executed at short notice.

Once the transaction is complete, H&R AG will directly hold 51% of the
shares of H&R China Holding GmbH. This increase in capital based in turn on
authorised capital will increase the company's subscribed capital, subject
to the partial use of the approved capital by the issue of 5,847,042 new
non-par bearer shares, supposing an increase of EUR14,947,725.52 to
EUR91,572,769.63.

The China-based activities are expected to be fully consolidated in H&R AG
for the first time by 30th September 2014. This takeover of the majority of
China-based business activities will result in the bundling of virtually
all the international business operations of the Hansen & Rosenthal Group
into H&R AG. H&R AG strengthens, with this move, its core business in the
chemical/pharmaceutical raw-materials sector, while continuing to build up
its higher margin, internationally growing presence in this specialty
business. The receipt of further H&R shares in exchange for parts of its
holding highlights the position of the Hansen & Rosenthal Group as the
majority shareholder and recognises its role as key investor in the
company.

Contact:
H&R AG, Investor Relations / Kommunikation, Ties Kaiser
Neuenkirchener Straße 8, 48499 Salzbergen
Phone.: +49 40 43218-321, Fax: +49 40 43218-390
Mail: Ties.Kaiser@hur.com 
www.hur.com  

H&R AG is a Prime Standard listed specialist chemicals company. It develops
and manufactures crude oil-based chemical and pharmaceutical products and
high-precision plastic parts.

Forward-looking statements and forecasts: This ad hoc notification contains
forward-looking statements. These statements are based on current estimates
and forecasts made by the Executive Board and the information available to
the Board at this time. Forward-looking statements should not be
interpreted as guarantees that the projected future developments and
results will materialise. Future developments and results are dependent on
a range of factors. They comprise various risks and imponderables and rest
on assumptions which may prove incorrect. We do not accept any obligation
to update the forward-looking statements made in this ad-hoc communication.


17.09.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      H&R AG
              Neuenkirchener Str. 8
              48499 Salzbergen
              Germany
Phone:        +49 (0)40 43 218 321 
Fax:          +49 (0)40 43 218 390
E-mail:       investor.relations@hur.com
Internet:     www.hur.com
ISIN:         DE0007757007
WKN:          775700
Listed:       Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard),
              Hamburg; Freiverkehr in Berlin, Hannover, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------